Total Payments
$25,542
2024 Payments
$3,043
Companies
47
Transactions
1,171
Medicare Patients
9,748
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$25,475 (99.7%)
Education$67.01 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,475 | 1,168 | 99.7% |
| Education | $67.01 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $5,407 | 241 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,731 | 136 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,093 | 121 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,861 | 85 | $0 (2024) |
| Genentech USA, Inc. | $1,776 | 78 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,232 | 113 | $0 (2020) |
| Mylan Specialty L.P. | $784.71 | 35 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $783.17 | 30 | $0 (2024) |
| Philips Electronics North America Corporation | $767.68 | 58 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $764.14 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,043 | 133 | GlaxoSmithKline, LLC. ($624.16) |
| 2023 | $2,965 | 124 | GlaxoSmithKline, LLC. ($659.47) |
| 2022 | $3,309 | 134 | GlaxoSmithKline, LLC. ($693.46) |
| 2021 | $2,843 | 124 | GlaxoSmithKline, LLC. ($628.54) |
| 2020 | $1,805 | 92 | GlaxoSmithKline, LLC. ($471.39) |
| 2019 | $4,134 | 209 | Boehringer Ingelheim Pharmaceuticals, Inc. ($801.33) |
| 2018 | $4,193 | 198 | GlaxoSmithKline, LLC. ($992.51) |
| 2017 | $3,249 | 157 | GlaxoSmithKline, LLC. ($618.38) |
All Payment Transactions
1,171 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Immunology | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/26/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $26.33 | General |
| Category: HFCWO | ||||||
| 11/25/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $30.61 | General |
| Category: Cardiology | ||||||
| 11/24/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $4.41 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/28/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.59 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: VACCINES | ||||||
| 09/24/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,601 | 3,593 | $1.2M | $310,125 |
| 2022 | 16 | 2,256 | 3,171 | $1.2M | $320,673 |
| 2021 | 15 | 2,447 | 3,573 | $1.2M | $360,589 |
| 2020 | 19 | 2,444 | 5,537 | $405,611 | $317,425 |
Total Patients
9,748
Total Services
15,874
Medicare Billing
$1.3M
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 408 | 627 | $277,134 | $69,512 | 25.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 191 | 460 | $186,760 | $50,943 | 27.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 349 | 600 | $162,000 | $44,216 | 27.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 49 | 170 | $124,950 | $34,231 | 27.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 174 | 180 | $80,460 | $21,833 | 27.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 127 | 133 | $78,603 | $21,426 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 100 | 100 | $57,900 | $15,192 | 26.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 341 | 405 | $38,880 | $10,051 | 25.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 62 | $38,254 | $9,830 | 25.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 115 | 123 | $24,969 | $6,491 | 26.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 115 | 123 | $23,862 | $6,462 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 60 | $18,780 | $4,277 | 22.8% |
| 71045 | X-ray of chest, 1 view | Office | 2023 | 128 | 145 | $13,630 | $3,508 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $11,426 | $2,521 | 22.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 21 | 21 | $9,639 | $2,513 | 26.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 27 | 27 | $5,400 | $2,041 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 15 | $4,980 | $1,364 | 27.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $2,295 | $971.46 | 42.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 82 | 82 | $3,280 | $879.86 | 26.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 103 | 103 | $2,884 | $770.44 | 26.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 88 | 88 | $2,640 | $710.16 | 26.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 13 | 13 | $1,573 | $381.58 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 390 | 618 | $275,628 | $69,200 | 25.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 308 | 640 | $224,640 | $61,459 | 27.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 84 | 248 | $188,976 | $51,732 | 27.4% |
About Dr. Gary Freeberg, M.D
Dr. Gary Freeberg, M.D is a Pulmonary Disease healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326086208.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Freeberg, M.D has received a total of $25,542 in payments from pharmaceutical and medical device companies, with $3,043 received in 2024. These payments were reported across 1,171 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($25,475).
As a Medicare-enrolled provider, Freeberg has provided services to 9,748 Medicare beneficiaries, totaling 15,874 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Great Neck, NY
- Active Since 06/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1326086208
Products in Payments
- NUCALA (Biological) $2,668
- TRELEGY ELLIPTA (Drug) $1,778
- OFEV (Drug) $1,589
- Xolair (Biological) $1,224
- DUPIXENT (Biological) $1,047
- STIOLTO RESPIMAT (Drug) $800.11
- OPSUMIT (Drug) $763.97
- UPTRAVI (Drug) $546.92
- SMARTVEST (Device) $532.80
- Arikayce (Drug) $497.48
- TEZSPIRE (Biological) $494.33
- SYMBICORT (Drug) $481.70
- OPSUMIT MACITENTAN (Drug) $473.76
- ANORO (Drug) $459.08
- LONHALA MAGNAIR (Drug) $407.79
- BREZTRI (Drug) $406.28
- STIOLTO (Drug) $396.47
- BEVESPI AEROSPHERE (Drug) $385.39
- Yupelri (Drug) $363.69
- XOLAIR (Biological) $360.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Great Neck
Dr. Jeffrey Wolf, M.d, M.D
Pulmonary Disease — Payments: $882,813
Pulmonary Disease $882,813
Dr. Robert Schreiber, M.d, M.D
Pulmonary Disease — Payments: $156,219
Pulmonary Disease $156,219
Dr. Alan Schecter, M.d, M.D
Pulmonary Disease — Payments: $148,961
Pulmonary Disease $148,961
Dr. Michael Como, M.d, M.D
Pulmonary Disease — Payments: $20,827
Pulmonary Disease $20,827
Dr. Jonathan Waxner, M.d, M.D
Pulmonary Disease — Payments: $20,436
Pulmonary Disease $20,436
Dr. Evan Sorett, M.d, M.D
Pulmonary Disease — Payments: $19,624
Pulmonary Disease $19,624